Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
AbbVie NYSE:ABBV |
402,17 B | 2,49% | 4/6 | 25,35% | -45,63% | 9,91% | UP |
|
Amgen NasdaqGS:AMGN |
203,21 B | 7,37% | 3/6 | 2,70% | -16,26% | -6,76% | UP |
|
Gilead Sciences NasdaqGS:GILD |
182,03 B | 3,30% | 5/6 | 4,64% | -61,59% | 9,12% | UP |
|
Alnylam Pharmaceuticals NasdaqGS:ALNY |
42,91 B | 46,06% | 4/6 | 50,26% | 0,19% | 39,40% | DOWN |
|
Alexion Pharmaceuticals NasdaqGM:ALXN |
40,34 B | 0,00% | 4/4 | 0,00% | 0,00% | -100,00% | UP |
|
Biogen NasdaqGS:BIIB |
27,63 B | -10,57% | 1/6 | -1,11% | 6,79% | 9,70% | UP |
|
Incyte NasdaqGS:INCY |
19,32 B | 41,79% | 6/6 | 9,03% | 25,71% | 13,29% | UP |
|
BioMarin Pharmaceutical NasdaqGS:BMRN |
11,71 B | 12,22% | 5/6 | 44,82% | 54,12% | 54,40% | UP |
|
Blueprint Medicines NasdaqGS:BPMC |
8,38 B | 45,26% | 4/6 | 42,18% | -48,48% | 0,64% | UP |
|
Arrowhead Pharmaceuticals NasdaqGS:ARWR |
8,50 B | 48,13% | 5/6 | -45,97% | 23,29% | 31,86% | UP |
|
Cidara Therapeutics NasdaqCM:CDTX |
6,97 B | -59,17% | 2/6 | 0,00% | -652349,57% | -100,00% | UP |
|
Arena Pharmaceuticals NasdaqGM:ARNA |
6,17 B | 0,00% | 0,00% | 0,00% | 0,00% | UP | |
|
Amicus Therapeutics NasdaqGM:FOLD |
4,51 B | 19,97% | 5/6 | 19,52% | -22,41% | 0,90% | UP |
|
Viking Therapeutics NasdaqCM:VKTX |
3,88 B | 0,00% | 0/4 | 28,84% | 0,00% | 196,04% | DOWN |
|
ACADIA Pharmaceuticals NasdaqGS:ACAD |
3,85 B | 29,02% | 5/6 | 13,70% | 28,84% | 43,93% | DOWN |
|
ChemoCentryx NasdaqGS:CCXI |
3,74 B | 0,00% | 0/4 | 0,00% | 0,00% | -100,00% | UP |
|
CymaBay Therapeutics NasdaqGS:CBAY |
3,72 B | 0,00% | 1/4 | 0,00% | 0,00% | -100,00% | UP |
|
ADMA Biologics NasdaqGM:ADMA |
3,77 B | 45,53% | 5/6 | 33,13% | -94,97% | 89,75% | DOWN |
|
Catalyst Pharmaceuticals NasdaqCM:CPRX |
3,03 B | 40,93% | 5/6 | 5,37% | 22,46% | 41,19% | UP |
|
Travere Therapeutics NasdaqGM:TVTX |
2,67 B | 10,07% | 5/6 | 43,61% | -49,65% | 48,38% | UP |
